Indole compounds produced by gut microbiota after metabolizing tryptophan improve dysmotility in sepsis via the AHR-TRPA1 axis in enteric nerves
Jintao Zhang, Ziang Li, Tong Jin, Wanglin Zhang, Hongwei Shi, Kanlirong Wang, Jiayi Qi, Liqun Sun · 2025
Read Indole compounds produced by gut microbiota after metabolizing tryptophan improve dysmotility in sepsis via the AHR-TRPA1 axis in enteric nerves by Jintao Zhang, Ziang Li, Tong Jin, Wanglin Zhang, Hongwei Shi, Kanlirong Wang, Jiayi Qi, Liqun Sun (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12751468.txt.
Description
Zhang and co-authors test a gut-made compound that may restore gut motion in sepsis in a 2025 study. Sepsis often stalls the bowel, with bad knock-on effects. Gut germs turn a food amino acid into indole compounds. One such compound, FICZ, was given to septic zebrafish bred for the test.
Treated fish showed fewer invading white cells in the gut wall. Muscle strength and wave motion of the bowel recovered. A receptor gene and its partner channel gene rose in the gut. Boosting the receptor gene alone also eased a brake signal and freed motion. The authors name that receptor path as a drug target for septic guts.
Catalog record
| CREATOR | Jintao Zhang, Ziang Li, Tong Jin, Wanglin Zhang, Hongwei Shi, Kanlirong Wang, Jiayi Qi, Liqun Sun |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 46 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |